Novel chemical mediators in the resolution of inflammation: resolvins and protectins
about
Bipolar disorder and mechanisms of action of mood stabilizersDHA supplementation: current implications in pregnancy and childhoodReduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.Reduction of novel circulating long-chain fatty acids in colorectal cancer patients is independent of tumor burden and correlates with age.Chronic oral or intraarticular administration of docosahexaenoic acid reduces nociception and knee edema and improves functional outcomes in a mouse model of Complete Freund's Adjuvant-induced knee arthritis.Dietary long-chain omega-3 fatty acids do not diminish eosinophilic pulmonary inflammation in mice.Extracellular-derived calcium does not initiate in vivo neurotransmission involving docosahexaenoic acid.N-Docosahexaenoylethanolamide promotes development of hippocampal neurons.Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment.Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brainω-3 Tear Film Lipids Correlate With Clinical Measures of Dry Eye.Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia.Biogenic synthesis, purification, and chemical characterization of anti-inflammatory resolvins derived from docosapentaenoic acid (DPAn-6).12/15-lipoxygenase expression is increased in oligodendrocytes and microglia of periventricular leukomalaciaWhole-body synthesis secretion of docosahexaenoic acid from circulating eicosapentaenoic acid in unanesthetized rats.Paradigm shift in the pharmacological management of periodontal diseases.Dietary modulation of the inflammatory cascade.Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability.Oral fish oil positively influences nutritional-inflammatory risk in patients with haematological malignancies during chemotherapy with an impact on long-term survival: a randomised clinical trial.Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both?Human serum-derived hydroxy long-chain fatty acids exhibit anti-inflammatory and anti-proliferative activity.Dietary ganglioside reduces proinflammatory signaling in the intestine.Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin.Docosahexaenoic acid reduces inflammation and joint destruction in mice with collagen-induced arthritis.(n-3) long-chain PUFA differentially affect resistance to Pseudomonas aeruginosa infection of male and female cftr-/- mice.Can inflammation be resolved in Alzheimer's disease?
P2860
Q22252332-AB8F0EFA-D73B-4D2B-B608-F24494652F9FQ27006939-8A48D56F-DDD6-4289-986A-0D4F9EEBD47AQ33531335-25BC6251-8902-4E56-9A1D-032C3BA4C6F6Q33757924-2252CA08-5870-4E92-97E1-3ADEA4F74FFAQ33765435-E2513385-B663-4498-954C-31ACFED58F59Q33799635-7C5578E8-67A4-4CB8-97B4-A6DE5CC7681BQ33993276-A7D21BA7-7AC1-4DD8-AED5-B798704AC20AQ35202551-F8687F5B-71B3-4AF7-8A9B-616435825575Q35742545-323DC177-FD3E-48E9-8101-7E86C6A84CEBQ36217965-71FC91B0-C7DF-44BE-A7FD-ABA663DEE412Q36338174-397D435C-E236-47CD-9E06-014372731F60Q36872931-AA11894A-F710-4256-AF63-FEC3F2611CF8Q37142087-98AE9BA2-7FD9-4A11-8D76-846FD0A13E73Q37200840-DBE87296-48E2-4887-86D5-4AB7D3CB2EA9Q37385634-93BDB16D-3401-48D0-A35A-155D73C6F190Q37430616-8AC4652F-05F3-412F-9508-89150820C7A3Q37964882-4B837F9E-AA8E-47C5-B083-346FEB2CF9A4Q38169805-D2750FAC-87C6-417A-86D2-E5CE32A35D56Q38784992-F3CD99E5-878E-4A96-BF40-262C69CDB7ACQ38856584-1E062723-E5FA-410A-B8D2-D1C7C121D121Q39427167-C6489B21-5418-45DB-9954-55567809F6AAQ39541011-155F214C-E211-46FB-9492-CABAE430FFA6Q42108943-907B882F-A62A-4C24-956C-8FFB3DE542A3Q43007771-947F1AE1-3BD3-4E78-9598-4B410FF46442Q44060152-134C70DD-64B3-4715-9BA7-681CBA84C404Q51470852-66999157-08EA-4B34-A79C-F26DF149529DQ58793290-FF06DFBD-FD70-4C6D-A717-2BA65C0B7CEC
P2860
Novel chemical mediators in the resolution of inflammation: resolvins and protectins
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Novel chemical mediators in the resolution of inflammation: resolvins and protectins
@ast
Novel chemical mediators in the resolution of inflammation: resolvins and protectins
@en
Novel chemical mediators in the resolution of inflammation: resolvins and protectins
@nl
type
label
Novel chemical mediators in the resolution of inflammation: resolvins and protectins
@ast
Novel chemical mediators in the resolution of inflammation: resolvins and protectins
@en
Novel chemical mediators in the resolution of inflammation: resolvins and protectins
@nl
prefLabel
Novel chemical mediators in the resolution of inflammation: resolvins and protectins
@ast
Novel chemical mediators in the resolution of inflammation: resolvins and protectins
@en
Novel chemical mediators in the resolution of inflammation: resolvins and protectins
@nl
P3181
P1476
Novel chemical mediators in the resolution of inflammation: resolvins and protectins
@en
P2093
Charles N Serhan
P304
P3181
P356
10.1016/J.ATC.2006.01.003
P407
P577
2006-06-01T00:00:00Z